 | • レポートコード：20QY06-05916 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、止血剤のグローバル市場について種類別（ゲル化スポンジ、酸化再生セルロース系止血剤、その他）、用途別（病院、外科センター、老人ホーム）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・止血剤市場の概要 ・世界の主要地域別止血剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の止血剤市場規模2015-2026：種類別（ゲル化スポンジ、酸化再生セルロース系止血剤、その他） ・世界の止血剤市場規模2015-2026：用途別（病院、外科センター、老人ホーム） ・止血剤の北米市場規模2015-2020 ・止血剤のヨーロッパ市場規模2015-2020 ・止血剤の中国市場規模2015-2020 ・止血剤の日本市場規模2015-2020 ・止血剤の東南アジア市場規模2015-2020 ・止血剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Ethicon、Pfizer、Baxter International、C. R. Bard、The Medicines Company、Anika Therapeutics、Advanced Medical Solutions、Integra LifeSciences、B Braun Melsungen、Gelita Medical、Equimedical、Vascular Solutions、Marine Polymer Technologies、Z-Medica、CryoLife、BioCer Entwicklungs、Biom’Up SAS） ・止血剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・止血剤の市場動向・機会・課題 ・調査の結論 |
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
Market Analysis and Insights: Global Hemostatic Agents Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Hemostatic Agents market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Hemostatic Agents industry.
Based on our recent survey, we have several different scenarios about the Hemostatic Agents YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Hemostatic Agents will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Hemostatic Agents Scope and Market Size
The global Hemostatic Agents market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hemostatic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Hemostatic Agents market is segmented into
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Segment by Application, the Hemostatic Agents market is segmented into
Hospitals
Surgical Centers
Nursing Homes
The Hemostatic Agents market is analysed and market size information is provided by regions (countries). Segment by Application, the Hemostatic Agents market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hemostatic Agents Market Share Analysis
Hemostatic Agents market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hemostatic Agents business, the date to enter into the Hemostatic Agents market, Hemostatic Agents product introduction, recent developments, etc.
The major vendors covered:
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS
1 Hemostatic Agents Market Overview
1.1 Hemostatic Agents Product Scope
1.2 Hemostatic Agents Segment by Type
1.2.1 Global Hemostatic Agents Sales by Type (2020-2026)
1.2.2 Gelation Sponge
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Others
1.3 Hemostatic Agents Segment by Application
1.3.1 Global Hemostatic Agents Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Nursing Homes
1.4 Hemostatic Agents Market Estimates and Forecasts (2015-2026)
1.4.1 Global Hemostatic Agents Sales Growth Rate (2015-2026)
1.4.2 Global Hemostatic Agents Revenue and Growth Rate (2015-2026)
1.4.3 Global Hemostatic Agents Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Hemostatic Agents Industry Impact
1.5.1 How the Covid-19 is Affecting the Hemostatic Agents Industry
1.5.1.1 Hemostatic Agents Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Hemostatic Agents Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Hemostatic Agents Players to Combat Covid-19 Impact
2 Hemostatic Agents Estimate and Forecast by Region
2.1 Global Hemostatic Agents Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Hemostatic Agents Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Hemostatic Agents Sales Market Share by Region (2015-2020)
2.2.2 Global Hemostatic Agents Revenue Market Share by Region (2015-2020)
2.3 Global Hemostatic Agents Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Hemostatic Agents Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Hemostatic Agents Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Hemostatic Agents Estimates and Projections (2015-2026)
2.4.2 Europe Hemostatic Agents Estimates and Projections (2015-2026)
2.4.3 China Hemostatic Agents Estimates and Projections (2015-2026)
2.4.4 Japan Hemostatic Agents Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Hemostatic Agents Estimates and Projections (2015-2026)
2.4.6 India Hemostatic Agents Estimates and Projections (2015-2026)
3 Global Hemostatic Agents Competition Landscape by Players
3.1 Global Top Hemostatic Agents Players by Sales (2015-2020)
3.2 Global Top Hemostatic Agents Players by Revenue (2015-2020)
3.3 Global Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemostatic Agents as of 2019)
3.4 Global Hemostatic Agents Average Price by Company (2015-2020)
3.5 Manufacturers Hemostatic Agents Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Hemostatic Agents Players (Opinion Leaders)
4 Global Hemostatic Agents Market Size by Type
4.1 Global Hemostatic Agents Historic Market Review by Type (2015-2020)
4.1.1 Global Hemostatic Agents Sales Market Share by Type (2015-2020)
4.1.2 Global Hemostatic Agents Revenue Market Share by Type (2015-2020)
4.1.3 Global Hemostatic Agents Price by Type (2014-2020)
4.2 Global Hemostatic Agents Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Hemostatic Agents Sales Forecast by Type (2021-2026)
4.2.2 Global Hemostatic Agents Revenue Forecast by Type (2021-2026)
4.2.3 Global Hemostatic Agents Price Forecast by Type (2021-2026)
5 Global Hemostatic Agents Market Size by Application
5.1 Global Hemostatic Agents Historic Market Review by Application (2015-2020)
5.1.1 Global Hemostatic Agents Sales Market Share by Application (2015-2020)
5.1.2 Global Hemostatic Agents Revenue Market Share by Application (2015-2020)
5.1.3 Global Hemostatic Agents Price by Application (2015-2020)
5.2 Global Hemostatic Agents Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Hemostatic Agents Sales Forecast by Application (2021-2026)
5.2.2 Global Hemostatic Agents Revenue Forecast by Application (2021-2026)
5.2.3 Global Hemostatic Agents Price Forecast by Application (2021-2026)
3 North America Hemostatic Agents Market Facts & Figures
3.2 North America Hemostatic Agents Sales Market Share by Company (2015-2020)
3.3 North America Hemostatic Agents Sales Market Share by Type (2015-2020)
3.4 North America Hemostatic Agents Sales Market Share by Application (2015-2020)
4 Europe Hemostatic Agents Market Facts & Figures
4.2 Europe Hemostatic Agents Sales Market Share by Company (2015-2020)
4.3 Europe Hemostatic Agents Sales Market Share by Type (2015-2020)
4.4 Europe Hemostatic Agents Sales Market Share by Application (2015-2020)
5 China Hemostatic Agents Market Facts & Figures
5.2 China Hemostatic Agents Sales Market Share by Company (2015-2020)
5.3 China Hemostatic Agents Sales Market Share by Type (2015-2020)
5.4 China Hemostatic Agents Sales Market Share by Application (2015-2020)
6 Japan Hemostatic Agents Market Facts & Figures
6.2 Japan Hemostatic Agents Sales Market Share by Company (2015-2020)
6.3 Japan Hemostatic Agents Sales Market Share by Type (2015-2020)
6.4 Japan Hemostatic Agents Sales Market Share by Application (2015-2020)
7 Southeast Asia Hemostatic Agents Market Facts & Figures
7.2 Southeast Asia Hemostatic Agents Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Hemostatic Agents Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Hemostatic Agents Sales Market Share by Application (2015-2020)
8 India Hemostatic Agents Market Facts & Figures
8.2 India Hemostatic Agents Sales Market Share by Company (2015-2020)
8.3 India Hemostatic Agents Sales Market Share by Type (2015-2020)
8.4 India Hemostatic Agents Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Hemostatic Agents Business
12.1 Ethicon
12.1.1 Ethicon Hemostatic Agents Corporation Information
12.1.2 Ethicon Hemostatic Agents Business Overview and Total Revenue
12.1.3 Ethicon Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Ethicon Hemostatic Agents Products Offered
12.1.5 Ethicon Recent Development
12.2 Pfizer
12.2.1 Pfizer Hemostatic Agents Corporation Information
12.2.2 Pfizer Hemostatic Agents Business Overview and Total Revenue
12.2.3 Pfizer Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Hemostatic Agents Products Offered
12.2.5 Pfizer Recent Development
12.3 Baxter International
12.3.1 Baxter International Hemostatic Agents Corporation Information
12.3.2 Baxter International Hemostatic Agents Business Overview and Total Revenue
12.3.3 Baxter International Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Baxter International Hemostatic Agents Products Offered
12.3.5 Baxter International Recent Development
12.4 C. R. Bard
12.4.1 C. R. Bard Hemostatic Agents Corporation Information
12.4.2 C. R. Bard Hemostatic Agents Business Overview and Total Revenue
12.4.3 C. R. Bard Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.4.4 C. R. Bard Hemostatic Agents Products Offered
12.4.5 C. R. Bard Recent Development
12.5 The Medicines Company
12.5.1 The Medicines Company Hemostatic Agents Corporation Information
12.5.2 The Medicines Company Hemostatic Agents Business Overview and Total Revenue
12.5.3 The Medicines Company Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.5.4 The Medicines Company Hemostatic Agents Products Offered
12.5.5 The Medicines Company Recent Development
12.6 Anika Therapeutics
12.6.1 Anika Therapeutics Hemostatic Agents Corporation Information
12.6.2 Anika Therapeutics Hemostatic Agents Business Overview and Total Revenue
12.6.3 Anika Therapeutics Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Anika Therapeutics Hemostatic Agents Products Offered
12.6.5 Anika Therapeutics Recent Development
12.7 Advanced Medical Solutions
12.7.1 Advanced Medical Solutions Hemostatic Agents Corporation Information
12.7.2 Advanced Medical Solutions Hemostatic Agents Business Overview and Total Revenue
12.7.3 Advanced Medical Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Advanced Medical Solutions Hemostatic Agents Products Offered
12.7.5 Advanced Medical Solutions Recent Development
12.8 Integra LifeSciences
12.8.1 Integra LifeSciences Hemostatic Agents Corporation Information
12.8.2 Integra LifeSciences Hemostatic Agents Business Overview and Total Revenue
12.8.3 Integra LifeSciences Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Integra LifeSciences Hemostatic Agents Products Offered
12.8.5 Integra LifeSciences Recent Development
12.9 B Braun Melsungen
12.9.1 B Braun Melsungen Hemostatic Agents Corporation Information
12.9.2 B Braun Melsungen Hemostatic Agents Business Overview and Total Revenue
12.9.3 B Braun Melsungen Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.9.4 B Braun Melsungen Hemostatic Agents Products Offered
12.9.5 B Braun Melsungen Recent Development
12.10 Gelita Medical
12.10.1 Gelita Medical Hemostatic Agents Corporation Information
12.10.2 Gelita Medical Hemostatic Agents Business Overview and Total Revenue
12.10.3 Gelita Medical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Gelita Medical Hemostatic Agents Products Offered
12.10.5 Gelita Medical Recent Development
12.11 Equimedical
12.11.1 Equimedical Hemostatic Agents Corporation Information
12.11.2 Equimedical Hemostatic Agents Business Overview and Total Revenue
12.11.3 Equimedical Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Equimedical Hemostatic Agents Products Offered
12.11.5 Equimedical Recent Development
12.12 Vascular Solutions
12.12.1 Vascular Solutions Hemostatic Agents Corporation Information
12.12.2 Vascular Solutions Hemostatic Agents Business Overview and Total Revenue
12.12.3 Vascular Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Vascular Solutions Hemostatic Agents Products Offered
12.12.5 Vascular Solutions Recent Development
12.13 Marine Polymer Technologies
12.13.1 Marine Polymer Technologies Hemostatic Agents Corporation Information
12.13.2 Marine Polymer Technologies Hemostatic Agents Business Overview and Total Revenue
12.13.3 Marine Polymer Technologies Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Marine Polymer Technologies Hemostatic Agents Products Offered
12.13.5 Marine Polymer Technologies Recent Development
12.14 Z-Medica
12.14.1 Z-Medica Hemostatic Agents Corporation Information
12.14.2 Z-Medica Hemostatic Agents Business Overview and Total Revenue
12.14.3 Z-Medica Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Z-Medica Hemostatic Agents Products Offered
12.14.5 Z-Medica Recent Development
12.15 CryoLife
12.15.1 CryoLife Hemostatic Agents Corporation Information
12.15.2 CryoLife Hemostatic Agents Business Overview and Total Revenue
12.15.3 CryoLife Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.15.4 CryoLife Hemostatic Agents Products Offered
12.15.5 CryoLife Recent Development
12.16 BioCer Entwicklungs
12.16.1 BioCer Entwicklungs Hemostatic Agents Corporation Information
12.16.2 BioCer Entwicklungs Hemostatic Agents Business Overview and Total Revenue
12.16.3 BioCer Entwicklungs Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.16.4 BioCer Entwicklungs Hemostatic Agents Products Offered
12.16.5 BioCer Entwicklungs Recent Development
12.17 Biom’Up SAS
12.17.1 Biom’Up SAS Hemostatic Agents Corporation Information
12.17.2 Biom’Up SAS Hemostatic Agents Business Overview and Total Revenue
12.17.3 Biom’Up SAS Hemostatic Agents Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Biom’Up SAS Hemostatic Agents Products Offered
12.17.5 Biom’Up SAS Recent Development
13 Hemostatic Agents Manufacturing Cost Analysis
13.1 Hemostatic Agents Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hemostatic Agents
13.4 Hemostatic Agents Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hemostatic Agents Distributors List
14.3 Hemostatic Agents Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Hemostatic Agents Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Hemostatic Agents Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Hemostatic Agents Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Hemostatic Agents Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Hemostatic Agents Players to Combat Covid-19 Impact
Table 8. Global Market Hemostatic Agents Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Hemostatic Agents Sales (K Units) by Region (2015-2020)
Table 10. Global Hemostatic Agents Sales Market Share by Region (2015-2020)
Table 11. Global Hemostatic Agents Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Hemostatic Agents Revenue Share by Region (2015-2020)
Table 13. Global Hemostatic Agents Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Hemostatic Agents Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Hemostatic Agents Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Hemostatic Agents Revenue Share Forecast by Region (2021-2026)
Table 17. Global Hemostatic Agents (K Units) of Key Companies (2015-2020)
Table 18. Global Hemostatic Agents Sales Share by Company (2015-2020)
Table 19. Global Hemostatic Agents Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Hemostatic Agents Revenue Share by Company (2015-2020)
Table 21. Global Hemostatic Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemostatic Agents as of 2019)
Table 22. Global Hemostatic Agents Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Hemostatic Agents Manufacturing Sites and Area Served
Table 24. Manufacturers Hemostatic Agents Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Hemostatic Agents Players
Table 27. Global Hemostatic Agents Sales (K Units) by Type (2015-2020)
Table 28. Global Hemostatic Agents Sales Share by Type (2015-2020)
Table 29. Global Hemostatic Agents Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Hemostatic Agents Price (K Units) by Type (2015-2020)
Table 31. Global Hemostatic Agents Sales Share by Type (2021-2026)
Table 32. Global Hemostatic Agents Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Hemostatic Agents Revenue Share by Type (2021-2026)
Table 34. Global Hemostatic Agents Price (K Units) by Type (2021-2026)
Table 35. Global Hemostatic Agents Sales (K Units) by Application (2015-2020)
Table 36. Global Hemostatic Agents Sales Share by Application (2015-2020)
Table 37. Global Hemostatic Agents Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Hemostatic Agents Price (K Units) by Application (2015-2020)
Table 39. Global Hemostatic Agents Sales (K Units) by Application (2021-2026)
Table 40. Global Hemostatic Agents Sales Share by Application (2021-2026)
Table 41. Global Hemostatic Agents Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Hemostatic Agents Revenue Share by Application (2021-2026)
Table 43. Global Hemostatic Agents Price (K Units) by Application (2021-2026)
Table 44. United States Hemostatic Agents Sales (K Units) by Company (2015-2020)
Table 45. United States Hemostatic Agents Sales Market Share by Company (2015-2020)
Table 46. United States Hemostatic Agents Sales (K Units) by Type (2015-2020)
Table 47. United States Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 48. United States Hemostatic Agents Sales (K Units) by Application (2015-2020)
Table 49. United States Hemostatic Agents Sales Market Share by Application (2015-2020)
Table 50. Europe Hemostatic Agents Sales (K Units) by Company (2015-2020)
Table 51. Europe Hemostatic Agents Sales Market Share by Company (2015-2020)
Table 52. Europe Hemostatic Agents Sales (K Units) by Type (2015-2020)
Table 53. Europe Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 54. Europe Hemostatic Agents Sales (K Units) by Application (2015-2020)
Table 55. Europe Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 56. China Hemostatic Agents Sales (K Units) by Company (2015-2020)
Table 57. China Hemostatic Agents Sales Market Share by Company (2015-2020)
Table 58. China Hemostatic Agents Sales (K Units) by Type (2015-2020)
Table 59. China Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 60. China Hemostatic Agents Sales (K Units) by Application (2015-2020)
Table 61. China Hemostatic Agents Sales Market Share by Application (2015-2020)
Table 62. Japan Hemostatic Agents Sales (K Units) by Company (2015-2020)
Table 63. Japan Hemostatic Agents Sales Market Share by Company (2015-2020)
Table 64. Japan Hemostatic Agents Sales (K Units) by Type (2015-2020)
Table 65. Japan Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 66. Japan Hemostatic Agents Sales (K Units) by Application (2015-2020)
Table 67. Japan Hemostatic Agents Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Hemostatic Agents Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Hemostatic Agents Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Hemostatic Agents Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Hemostatic Agents Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Hemostatic Agents Sales Market Share by Application (2015-2020)
Table 74. India Hemostatic Agents Sales (K Units) by Company (2015-2020)
Table 75. India Hemostatic Agents Sales Market Share by Company (2015-2020)
Table 76. India Hemostatic Agents Sales (K Units) by Type (2015-2020)
Table 77. India Hemostatic Agents Sales Market Share by Type (2015-2020)
Table 78. India Hemostatic Agents Sales (K Units) by Application (2015-2020)
Table 79. India Hemostatic Agents Sales Market Share by Application (2015-2020)
Table 80. Ethicon Corporation Information
Table 81. Ethicon Description and Business Overview
Table 82. Ethicon Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Ethicon Hemostatic Agents Product
Table 84. Ethicon Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Pfizer Hemostatic Agents Product
Table 89. Pfizer Recent Development
Table 90. Baxter International Corporation Information
Table 91. Baxter International Description and Business Overview
Table 92. Baxter International Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Baxter International Hemostatic Agents Product
Table 94. Baxter International Recent Development
Table 95. C. R. Bard Corporation Information
Table 96. C. R. Bard Description and Business Overview
Table 97. C. R. Bard Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. C. R. Bard Hemostatic Agents Product
Table 99. C. R. Bard Recent Development
Table 100. The Medicines Company Corporation Information
Table 101. The Medicines Company Description and Business Overview
Table 102. The Medicines Company Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. The Medicines Company Hemostatic Agents Product
Table 104. The Medicines Company Recent Development
Table 105. Anika Therapeutics Corporation Information
Table 106. Anika Therapeutics Description and Business Overview
Table 107. Anika Therapeutics Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Anika Therapeutics Hemostatic Agents Product
Table 109. Anika Therapeutics Recent Development
Table 110. Advanced Medical Solutions Corporation Information
Table 111. Advanced Medical Solutions Description and Business Overview
Table 112. Advanced Medical Solutions Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Advanced Medical Solutions Hemostatic Agents Product
Table 114. Advanced Medical Solutions Recent Development
Table 115. Integra LifeSciences Corporation Information
Table 116. Integra LifeSciences Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Integra LifeSciences Description and Business Overview
Table 118. Integra LifeSciences Hemostatic Agents Product
Table 119. Integra LifeSciences Recent Development
Table 120. B Braun Melsungen Corporation Information
Table 121. B Braun Melsungen Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. B Braun Melsungen Description and Business Overview
Table 123. B Braun Melsungen Hemostatic Agents Product
Table 124. B Braun Melsungen Recent Development
Table 125. Gelita Medical Corporation Information
Table 126. Gelita Medical Description and Business Overview
Table 127. Gelita Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Gelita Medical Hemostatic Agents Product
Table 129. Gelita Medical Recent Development
Table 130. Equimedical Corporation Information
Table 131. Equimedical Description and Business Overview
Table 132. Equimedical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Equimedical Hemostatic Agents Product
Table 134. Equimedical Recent Development
Table 135. Vascular Solutions Corporation Information
Table 136. Vascular Solutions Description and Business Overview
Table 137. Vascular Solutions Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Vascular Solutions Hemostatic Agents Product
Table 139. Vascular Solutions Recent Development
Table 140. Marine Polymer Technologies Corporation Information
Table 141. Marine Polymer Technologies Description and Business Overview
Table 142. Marine Polymer Technologies Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Marine Polymer Technologies Hemostatic Agents Product
Table 144. Marine Polymer Technologies Recent Development
Table 145. Z-Medica Corporation Information
Table 146. Z-Medica Description and Business Overview
Table 147. Z-Medica Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Z-Medica Hemostatic Agents Product
Table 149. Z-Medica Recent Development
Table 150. CryoLife Corporation Information
Table 151. CryoLife Description and Business Overview
Table 152. CryoLife Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. CryoLife Hemostatic Agents Product
Table 154. CryoLife Recent Development
Table 155. BioCer Entwicklungs Corporation Information
Table 156. BioCer Entwicklungs Description and Business Overview
Table 157. BioCer Entwicklungs Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. BioCer Entwicklungs Hemostatic Agents Product
Table 159. BioCer Entwicklungs Recent Development
Table . Biom’Up SAS Corporation Information
Table . Biom’Up SAS Description and Business Overview
Table . Biom’Up SAS Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Biom’Up SAS Hemostatic Agents Product
Table . Biom’Up SAS Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Hemostatic Agents Distributors List
Table 168. Hemostatic Agents Customers List
Table 169. Market Key Trends
Table 170. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 171. Key Challenges
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemostatic Agents Product Picture
Figure 2. Global Hemostatic Agents Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hemostatic Agents Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Surgical Centers Examples
Figure 8. Nursing Homes Examples
Figure 9. Global Hemostatic Agents Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Hemostatic Agents Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Hemostatic Agents Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Hemostatic Agents Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Hemostatic Agents Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Hemostatic Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Hemostatic Agents Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Hemostatic Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Hemostatic Agents Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Hemostatic Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Hemostatic Agents Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Hemostatic Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Hemostatic Agents Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Hemostatic Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Hemostatic Agents Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Hemostatic Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Hemostatic Agents Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Hemostatic Agents Players Market Share by Revenue in Hemostatic Agents 2015 & 2019
Figure 27. Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Hemostatic Agents Revenue Share by Type (2015-2020)
Figure 29. Global Hemostatic Agents Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Hemostatic Agents Revenue Share by Application (2015-2020)
Figure 31. Global Hemostatic Agents Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Hemostatic Agents Sales Market Share by Type in 2019
Figure 33. United States Hemostatic Agents Sales Market Share by Type in 2019
Figure 34. Europe Hemostatic Agents Sales Market Share by Company in 2019
Figure 35. Europe Hemostatic Agents Sales Market Share by Type in 2019
Figure 36. Europe Hemostatic Agents Sales Market Share by Application in 2019
Figure 37. China Hemostatic Agents Sales Market Share by Company in 2019
Figure 38. China Hemostatic Agents Sales Market Share by Type in 2019
Figure 39. China Hemostatic Agents Sales Market Share by Application in 2019
Figure 40. Japan Hemostatic Agents Sales Market Share by Company in 2019
Figure 41. Japan Hemostatic Agents Sales Market Share by Type in 2019
Figure 42. Japan Hemostatic Agents Sales Market Share by Application in 2019
Figure 43. Southeast Asia Hemostatic Agents Sales Market Share by Company in 2019
Figure 44. Southeast Asia Hemostatic Agents Sales Market Share by Type in 2019
Figure 45. Southeast Asia Hemostatic Agents Sales Market Share by Application in 2019
Figure 46. India Hemostatic Agents Sales Market Share by Company in 2019
Figure 47. India Hemostatic Agents Sales Market Share by Type in 2019
Figure 48. India Hemostatic Agents Sales Market Share by Application in 2019
Figure 49. Ethicon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Baxter International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. C. R. Bard Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. The Medicines Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Anika Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Advanced Medical Solutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Integra LifeSciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. B Braun Melsungen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Gelita Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Equimedical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Vascular Solutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Marine Polymer Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Z-Medica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. CryoLife Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. BioCer Entwicklungs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Biom’Up SAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Key Raw Materials Price Trend
Figure 67. Manufacturing Cost Structure of Hemostatic Agents
Figure 68. Manufacturing Process Analysis of Hemostatic Agents
Figure 69. Hemostatic Agents Industrial Chain Analysis
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Figure 72. Porter's Five Forces Analysis
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
医療用止血剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Medical Hemostatic Agents market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Medical Hemostatic …- 止血弁の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Hemostatic Valves market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hemostatic Valves market re…
- 穿刺部止血デバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global External Hemostatic Device market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The External Hemostati…
- 生物学的膨張剤の世界市場レポート2020 Market Analysis and Insights: Global Biological Leavening Agents Market The global Biological Leavening Agents market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Biological Leavening Agents Scope and Market …
- 化学膨張剤の世界市場レポート2020 Market Analysis and Insights: Global Chemical Leavening Agents Market The global Chemical Leavening Agents market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Chemical Leavening Agents Scope and Market Size T…